Concepedia

Author

Robert O. Sayers

Novartis (Switzerland)

Also Known As

Robert O Sayers, Robert O. Sayers

8

Publications

556

Citations

7

H-Index

53

Concepts

All Affiliations

Novartis (Switzerland)Idera Pharmaceuticals (United States)
RO

About

Robert O. Sayers is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

545

2

Natural Sciences

4

4

147

3

Engineering

1

1

11

4

Health Sciences

1

1

19

5

Public Health

1

1

21

Robert O. Sayers

×

7

Publications

556

Citations

7

H-Index

YearCitations

In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system

Anu Srinivasan, Kevin A. Roth, Robert O. Sayers,

Cell Death and Differentiation

1998

369

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong,

Journal of Medicinal Chemistry

2005

105

Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke

Steven D. Linton, Teresa Aja, Peter R. Allegrini,

Bioorganic & Medicinal Chemistry Letters

2004

21

Long‐term protection of brain tissue from cerebral ischemia by peripherally administered peptidomimetic caspase inhibitors

Thomas L. Deckwerth, Lisa M. Adams, Peter R. Allegrini,

Drug Development Research

2001

19

Structure–Activity relationships within a series of caspase inhibitors: effect of leaving group modifications

Brett R. Ullman, Teresa Aja, Thomas L. Deckwerth,

Bioorganic & Medicinal Chemistry Letters

2003

18

Structure–activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads

Brett R. Ullman, Teresa Aja, Ning Chen,

Bioorganic & Medicinal Chemistry Letters

2005

13

Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage

Priyanka Pandya, Robert O. Sayers, Joey Ting,

PLoS ONE

2020

11

Page 1